It was because the size and costs of doing this type of trial is far bigger thanks NEU’s checkbook,
But don’t exclude the possibility of a partnering deal dropping out of the blue one day.
Ann: Neuren completes Phelan-McDermid syndrome Phase 2 trial, page-30
-
- There are more pages in this discussion • 22 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$20.41 |
Change
-0.450(2.16%) |
Mkt cap ! $2.602B | |||
| Open | High | Low | Value | Volume |
| $20.45 | $20.61 | $20.26 | $1.021M | 49.93K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 259 | $20.36 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $20.40 | 40 | 1 |
View Market Depth
| Last trade - 10.50am 27/06/2024 (20 minute delay) ? |
| NEU (ASX) Chart |